M-Target

M-Target is a Japanese biotechnology company specializing in the discovery and development of therapeutic antibodies targeting complex membrane proteins. The company utilizes its proprietary M-Target technology to generate high-quality monoclonal antibodies against challenging targets such as G protein-coupled receptors (GPCRs), ion channels, and transporters. By overcoming the technical hurdles associated with membrane protein stabilization and antigen preparation, M-Target aims to address unmet medical needs in oncology and immunology. The company operates primarily as a drug discovery partner, leveraging its platform to support pharmaceutical pipelines through collaborative research and licensing agreements.